Kanceftri S 250mg/125mg Injection
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Kanceftri S 250mg/125mg Injection
Cefixime and Sulbactam 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial, completing the entire course even with symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Allergic reactions (skin rashes, pruritus, edema, dyspnea) necessitate prompt medical care. Inform your doctor of all current medications, and pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Rest, proper nutrition, and hydration are important for optimal recovery. Your doctor may order tests to monitor the medicine's impact.
Primary Ingredients of Kanceftri S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Kanceftri S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Kanceftri S 250mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kanceftri S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kanceftri S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Kanceftri S 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250mg/125mg Injection (Kanceftri S) merges the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Kanceftri S 250mg/125mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Kanceftri S 250mg/125mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data in humans, however, remain scarce.
Breast feedingCAUTION
Administering Kanceftri S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Kanceftri S 250mg/125mg Injection may induce drowsiness, blurred vision, or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kanceftri S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Individuals with severe hepatic impairment should use Kanceftri S 250mg/125mg Injection cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Dosage alteration for Kanceftri S 250mg/125mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Kanceftri S 250mg/125mg Injection :
Omitting a scheduled dose of Kanceftri S 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Kanceftri S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently